Dr. Okhravi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Fairfax Ave
Suite 201
Norfolk, VA 23507Phone+1 757-446-7040Fax+1 757-446-7049
Education & Training
- Hurley Medical Center/Michigan State UniversityResidency, Internal Medicine, 1999 - 2001
- St Louis University School of MedicineInternship, Transitional Year, 1998 - 1999
- Mashhad University of Medical SciencesClass of 1990
Certifications & Licensure
- VA State Medical License 2006 - 2026
- MN State Medical License 2007 - 2022
- TN State Medical License 2003 - 2021
- MI State Medical License 2001 - 2005
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Geriatric Medicine
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Escitalopram for Agitation in Alzheimer's Disease Start of enrollment: 2018 Jan 03
- New IDEAS: Imaging Dementia-Evidence for Amyloid Scanning Study Start of enrollment: 2020 Dec 17
- Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease Start of enrollment: 2021 Feb 26
- Join now to see all
Publications & Presentations
PubMed
- Benefits and risks of FDA-approved amyloid-targeting antibodies for treatment of early Alzheimer's disease: Navigating clinician-patient engagement.Dorene M Rentz, Paul S Aisen, Alireza Atri, Janice Hitchcock, Michael Irizarry
Alzheimer's & Dementia. 2024-11-01 - 8 citationsDownstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial.Olivia Wagemann, Haiyan Liu, Guoqiao Wang, Xinyu Shi, Tobias Bittner
JAMA Neurology. 2024-06-01 - Clinical Manifestations.Hamid Okhravi, Fang Fang, Brynn E Sheehan
Alzheimer's & Dementia. 2023-12-01
Journal Articles
- Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical TrialOlivia Wagemann 1 2, Haiyan Liu 1, Guoqiao Wang 3, Xinyu Shi 3, Tobias Bittner 4, Marzia A Scelsi 5, Martin R Farlow 6, David B Clifford 1, Charlene Supnet-Bell 1, Ann..., JAMA Neurology, 6/1/2024
- Towards Musculoskeletal Simulation-Aware Fall Injury Mitigation: Transfer Learning with Deep CNN for Fall DetectionHaben Yhdego; Jiang Li; Steven Morrison; Michel Audette; Christopher Paolini; Mahasweta Sarkar; Hamid Okhravi, the Institute of Electrical and Electronics Engineers, 4/1/2019
- Skin Angiosarcoma Masquerading as Hematoma in an Elderly WomanHamid R Okhravi*, Meenal Walia and Robert M Palmer, Journal of Geriatrics and Palliative Care, 3/3/2014
Press Mentions
- AHEAD Perspective: Carol’s JourneyApril 3rd, 2022
- EVMS Seeking Participants for Alzheimer’s Medication Research StudyAugust 25th, 2020
- Family manages memory loss with help from EVMS | my Story ...April 12th, 2021
- Join now to see all
Professional Memberships
- Fellow
External Links
- VCU Grand Roundshttps://www.youtube.com/watch?v=vWo0VgQ78_s
- Memory Clinic Registry Talkhttps://www.youtube.com/watch?v=bUAKQY2-RW0
- Dementia Friendly Healthcare and Community Symposium - 2024- University of North Dakotahttps://www.youtube.com/watch?v=tr1GT_fIRAk
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: